雷迪帕韦

雷迪帕韦（英语：Ledipasvir，亦作GS-5885）是吉利德科学研发的治疗C型肝炎的药物。在完成了Ⅲ期临床试验后，吉利德于2014年2月10日向美国联邦政府申请报批了固定剂量复方片剂，复方索非布韦雷迪帕韦片，用于第1基因型C型肝炎病毒感染的治疗。

The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.

单词	Ledipasvir
释义	Ledipasvir 中文百科雷迪帕韦雷迪帕韦（英语：Ledipasvir，亦作GS-5885）是吉利德科学研发的治疗C型肝炎的药物。在完成了Ⅲ期临床试验后，吉利德于2014年2月10日向美国联邦政府申请报批了固定剂量复方片剂，复方索非布韦雷迪帕韦片，用于第1基因型C型肝炎病毒感染的治疗。 The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin. 英语百科 Ledipasvir 雷迪帕韦 Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. After completing Phase III clinical trials, on February 10, 2014 Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.
随便看	sharing complex Sharing,Cost sharing criteria sharing criterion sharing data set sharing device sharing economies Sharing economy sharing electron sharing extra profit Sharing,Financial Risk sharing information sharing logical link sharing multiprocessing Sharing,Needle sharing of computer sharing of duplicate equipment sharing of foreign exchange earnings sharing of information sharing of load sharing of load between parallel operating machines in sharing of load sharing of losses sharing of opportunities, resources and rewards sharing of procedure segments sharing of programs

Ledipasvir

雷迪帕韦

Ledipasvir 雷迪帕韦